Methods of diagnosis early stage Parkinson's disease
Katunina, E.A.; Titova, N.V.; Avakian, G.N.
Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 110(12): 112-118
2010
ISSN/ISBN: 1997-7298 PMID: 21434466 Document Number: 638638
Document emailed within 1 workday
Related Documents
Broussolle, E. 2000: Dopa-therapy in the treatment of early stage Parkinson's disease Revue Neurologique (Paris) 156(2 Part 2): 91-97Szczudlik, A.; Rudzińska, M. 2007: Are dopamine agonists alternative therapy for levodopa in early stage of Parkinson's disease? Yes Neurologia i Neurochirurgia Polska 41(2 Suppl 1: S6-S9
Sharpar', V.D. 1984: Comparative evaluation of the various methods of early diagnosis and treatment of Legg-Perthes disease Ortopediia Travmatologiia i Protezirovanie 4: 14-18
Bürkle, G.; Sander, J.; Bürkle, V.; Vergau, W. 1971: Radiologic examination methods for the early diagnosis and disease process evaluation in experimentally induced tumors in rats and mice Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 114(5): 698-710
Jankovic, J. 2001: Parkinson's disease therapy: treatment of early and late disease Chinese Medical Journal 114(3): 227-234
Dickerson, L.M.; Young, S.E.; Simpson, W.M.; Nashelsky, J. 2005: Treatment of early Parkinson's disease American Family Physician 72(3): 497-500
Pacchetti, C.; Aglieri, R.; Mancini, F.; Martignoni, E.; Nappi, G. 1998: Active music therapy and Parkinson's disease: methods Functional Neurology 13(1): 57-67
Kraus, P.H.; Klotz, P.; Fischer, A.; Przuntek, H. 1987: Assessment of symptoms of Parkinson's disease by apparative methods Journal of Neural Transmission. Supplementum 25: 89-96
Stacy, M.; Brownlee, H.J. 1996: Treatment options for early Parkinson's disease American Family Physician 53(4): 1281-1287
Toda, H. 2011: Targeting methods in deep brain stimulation for Parkinson's disease No Shinkei Geka. Neurological Surgery 39(1): 25-35
Marttila, R. 2004: Which drug to use for the initiation of treatment for early Parkinson's disease Duodecim; Laaketieteellinen Aikakauskirja 120(5): 587-590
Csanda, E.; Tárczy, M. 1987: Selegiline in the early and late phases of Parkinson's disease Journal of Neural Transmission. Supplementum 25: 105-113
Petit, H. 1984: Early or late dopa therapy in Parkinson's disease Presse Medicale 13(36): 2213
Uldry, P.A.; Regli, F. 1991: Initial manifestations of Parkinson disease. Diagnosis and differential diagnosis Revue Medicale de la Suisse Romande 111(1): 3-8
García de Yébenes, J.; Bazán, E.; Mena, M.A.; Muradas, V.; Reiriz, J.; Romero, J.; González-Elipe, J. 1986: Clinical and biochemical aspects of early-onset Parkinson's disease Revista Clinica Espanola 178(7): 343-346
Olanow, C.Warren. 2002: The role of dopamine agonists in the treatment of early Parkinson's disease Neurology 58(4 Suppl 1): S33-S41
Jílek, D.; Dlouhý, P.; Svoboda, J.; Burianová, Z.; Svejda, J. 1991: Takayasu's disease. Detection of the early systemic stage of the disease in a pregnant woman Casopis Lekaru Ceskych 130(1): 20-23
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Gönül, A.S.; Aksu, M. 1999: SSRI-induced parkinsonism may be an early sign of future Parkinson's disease Journal of Clinical Psychiatry 60(6): 410
Suttrup, I.; Warnecke, T. 2016: Diagnosis of Parkinson's disease Medizinische Monatsschrift für Pharmazeuten 39(7): 282-285